Introduction
============

*In utero* environment critically affects the brain development, thereby modifying neurobehavior of the offspring after birth ([@B74]). Substances that are ingested by a pregnant woman can cross the placenta and adversely affect fetal development. Some are unavoidable medications due to the mother's medical condition, such as epilepsy or depression, but others are consumed by an expectant mother unbeknown to the risks and effects. In some cases, an excessive amount may be taken by a pregnant woman due to the addiction.

During brain development, newly generated neurons undergo morphological changes followed by migrating from the germinal layer through the intricate network of extracellular matrix to establish connections with other cells in a highly ordered fashion ([@B72], [@B73]; [@B62]). Two major modes of migration in the cerebral cortex are known ([@B14]; [@B30]). The first is radial migration. Excitatory neurons generated in the proliferative zones of the dorsal telencephalic primordium radially migrate toward the pial surface of the cerebral cortex along the radial axis. These neurons use the cellular processes that are elongated from the radial glial cells, which are ascending neural progenitor cells (NPCs), as the scaffold of their migration ([@B72]; [@B3]; [Figure 1](#F1){ref-type="fig"}). Once arriving at the superficial layer, the neurons detach from the radial glial processes to settle down in the cortical plate. Another mode of neuronal migration, known as tangential migration, is employed by inhibitory interneurons. Those neurons migrate tangentially from the ganglionic eminences (GE) to the cerebral cortex ([@B56]; [@B3]; [Figure 1](#F1){ref-type="fig"}).

![Modes of neuronal migration in cortical development. The schematic diagram illustrates two major modes of migration. Excitatory neurons migrate radially from ventricular surface toward the pial surface of the neocortex using radial glial cells as their scaffolds whereas the inhibitory neurons migrate tangentially from the ganglionic eminences to the neocortex.](fcell-07-00138-g001){#F1}

Any disturbances of these two modes of migration cause neuronal migration disorders (NMDs), and the consequent malformations are detectable by brain imaging in NMD patients ([@B79]). Profound cases of NMDs include lissencephaly, heterotopia, and focal dysplasia ([@B30]; [@B79]). Precise control of the migration and positioning of both excitatory and inhibitory neurons are particularly important for the formation of synaptic excitation and inhibition (E/I) balanced circuit in the brain. Therefore the E/I imbalance is the main cause of epilepsy in NMD patients ([@B14]). Other neurodevelopmental and psychiatric disorders, including autism spectrum disorders (ASD), and schizophrenia are also associated with NMDs ([@B11]).

In addition to the genetic causes, harmful prenatal environment also leads to neuronal migration defects ([@B62]). When developmental neurotoxicology first emerged, various paradigms of exposure were deployed in many species to recapitulate human pathophysiology, including defects of neuronal migration. Decades later, many recent studies have utilized genetic tools and cutting edge molecular techniques in those preclinical animal models to decipher the underlying mechanisms of neuronal migration defects under the stress exposure. In this review, we summarize such recent findings in animal research and discuss the mechanisms shared by various types of environmental stress as the targets of interventions.

Alcohol
=======

Prenatal alcohol exposure (PAE) is the cause of fetal alcohol spectrum disorders (FASD) ([@B45]; [@B10]; [@B78]; [@B105]). Alcohol consumed by a pregnant woman can easily cross the placenta, and increases fetal blood alcohol concentrations to the levels equivalent to those in maternal side within 2 h of ingestion ([@B9]). Affected individuals of FASD display a spectrum of defects, including facial malformations and neurobehavior impairments ([@B94]).

Depending on the timing of exposure to alcohol and the mother's drinking pattern, alcohol may have different effects on a child ([@B23]). A comprehensive transcriptome study of mice that were exposed to two acute doses (5 g/kg in total) of alcohol at various periods of brain development demonstrated that ethanol exposure at different developmental periods impacts differential biological processes ([@B48]). Notably, the genes that are associated with cell migration and differentiation were altered only in the brains exposed to alcohol on E14 and E16 which is equivalent to second trimester in humans ([@B48]).

Neuronal migration defects have been reported by many groups in animal models of PAE. In a binge-drinking model in which the mice were exposed to 5% w/w alcohol at E13.5--E16.5, defects of radial migration particularly affecting the populations of excitatory neurons were found in the somatosensory cortex ([@B19]; [Table 1](#T1){ref-type="table"}). These animals also showed a decrease of dendritic complexity in excitatory neurons and reduced tactile sensitivity ([@B19]). In another study using the same binge drinking paradigm (5% w/w E13.5--E16.5 exposure), the increase of interneurons derived from medial ganglionic eminence (MGE) in the medial prefrontal cortex (mPFC) was observed by using Nkx2.1Cre-Ai14 transgenic mice. This increase of interneurons in the mPFC is due to the increase of proliferation of the progenitor cells in MGE as well as earlier entrance of those neurons into the mPFC ([@B89]). Associated E/I imbalance that favors synaptic inhibition was also reported ([@B89]; [Table 1](#T1){ref-type="table"}). Chronic liquid administration of ethanol at lower dosage (1 or 2% w/v) from early to mid-gestational stages (E0.5--E14.5) increased the number of inhibitory interneurons in the neocortex([@B16]; [Table 1](#T1){ref-type="table"}).

###### 

Summary of different environmental exposure paradigm studies described in this review.

  Type of defect                           Exposure paradigm                               Model                                                                                                                                                                                                                                             
  ---------------------------------------- ----------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------- --------------------- ---------------------------- --------------------------------------- ---------------------- ---------
  Radial migration defect                  Ethanol                                         5% w/w, self -administered Liber-DeCarli liquid diet regimen                                                                    E13.5--E16.5          Second trimester             Thy1-YFP Tg mice                        E16.5                  [@B19]
                                           Hypoxia                                         7% oxygen for 8 min/h for 10 h per day                                                                                          E2--E20               First and second trimester   Sprague-Dawley rats                     P6                     [@B108]
                                                                                           7% oxygen for 3 h per day                                                                                                       E14 or E18            Second trimester             Wistar rats                             P5                     [@B101]
                                                                                           9% oxygen for 2 h per day                                                                                                       E13.5                                              C57BL/6J or Balb/cBYJ mice              E14                    [@B36]
                                           Methylmercury                                   0.01,0.1 or 1 mg/kg/day, IP injection                                                                                           E11--E21              First and second trimester   Sprague-Dawley rats                     P0, P3 and P7          [@B31]
                                           Glucocorticoids                                 200 μg/kg of DEX, daily SC injection                                                                                            E14.5--E20.5          Second trimester             Wistar rats                             E16.5--E21.5           [@B26]
  Tangential migration defect              Ethanol                                         1 or 2 % w/v, self-administered liquid diet regimen (Dam BAL 28.94 ± 1.97 mg/dL at E13.5)                                       E0.5--E14.5           First and second trimester   GAD67-GFP knock-in mice                 E14.5                  [@B16]
                                                                                           5% w/w, self-administered liquid diet regimen (Dam BAL 80 ± 21 mg/dL at E15.5)                                                  E13.5--E16.5          Second trimester             Nkx2.1-Ai14 (tdTomato) Tg mice          P70                    [@B89]
                                           Glucocorticoids                                 Stress induced GC, by restraint stress three times a day                                                                        E12--P0                                            GAD67-GFP knock-in mice                 E13, E14, E15 and P0   [@B92]
  Radial and tangential migration defect   Cocaine                                         20 mg/kg, SC injection twice a day                                                                                              E8--E12, E13 or E15   First and second trimester   Swiss Webster GAD67-GFP knock-in mice   E12, E13, and E15      [@B59]
  Migration speed defect                   Selective serotonin reuptake inhibitor (SSRI)   400 μM, 90 min exposure, cortical slices                                                                                        E17.5 and P0.5        Second trimester             C57BL/6 mice                            E17.5 and P0.5         [@B75]
                                           Ethanol                                         10 and 50 mM, acute exposure on cerebellar slices                                                                               P7 and P13            Third trimester              CD1 mice                                P7 and P13             [@B50]
                                           Methylmercury                                   Various of dose between 0.01 and 5.0 μg/g body weight                                                                           P6--P9                                             CD1 mice                                P10                    [@B22]
  Ectopic localization                     Maternal Immune Activation (MIA)                6000 plague-forming units (PFU) of human influenza virus one time IP injection or 20 mg/kg of poly(I:C) one time IP injection   E9.5 or E12.5         First trimester              Balb/c mice                             P11                    [@B87]
                                           Valproic acid (VPA)                             300 mg/kg, oral administration once a day                                                                                       E12--E14              Second trimester             C57BL/6 mice                            P84                    [@B82]
                                           Cocaine                                         20 mg/kg, IP injection twice a day                                                                                              E13--E14, E15--E16                                 Sprague-Dawley rats                     E15 and E17            [@B51]
                                                                                                                                                                                                                                                                                                                                             

BAL, blood alcohol level; IP, intraperitoneal; SC, subcutaneous.

Intracellular Ca^2+^ serves as a second messenger of various signaling, and dynamic oscillation of the intracellular Ca^2+^ is associated with neuronal migration ([@B49]). Interestingly, Kumada et al. reported the migration defect observed in cerebellar granule cells following ethanol exposure *ex vivo* were rescued by modifying the Ca^2+^ signaling ([Table 1](#T1){ref-type="table"}). The authors demonstrated that exposure to ethanol reduces the cGMP level, but increases the cAMP level in the tissue, resulting in changes of Ca^2+^ transients in the migrating neuron. Importantly, the neuronal migration defects were reversed by stimulating the brain with Ca^2+^ and cGMP or inhibiting cAMP signaling both *in vitro* and *in vivo* ([@B50]). Rescuing neuronal migration through changing Ca^2+^ and cyclic nucleotide signaling is mediated by activating the downstream targets that are essential for neuronal migration, such as protein kinase C (PKC), Ca^2+^/calmodulin-dependent protein kinase II (CaMKII), protein phosphatase 1 (PP1), Rho GTPase, mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI~3~K) ([@B39]; [@B88]; [@B109]; [@B47]).

As mentioned earlier, alcohol exposure changes the expressions of many genes that are associated with neuronal migration. Transcriptome analyses of human and mouse fetal cerebral cortices that were acutely exposed to alcohol demonstrated altered expressions of genes that are related to neuronal migration ([@B34]; [@B48]; [@B46]). Of note, a study on the expressions of splicing isoforms in the human brain revealed global exon skipping following alcohol exposure ([@B46]). Consequently, the functions of the encoded proteins may be different before and after alcohol exposure. However, how the changes in expressing protein isoforms lead to migration deficiency, and the mechanism of alcohol leading to global changes in RNA splicing remains to be investigated.

Cocaine
=======

In human, prenatal cocaine exposure (PCE) is associated with changes in cortical structure, physical and neurocognitive development in the offspring ([@B5]; [@B76]). The association between cocaine exposure in second trimester and poor motor development in the infants based on psychomotor developmental index (PDI) was reported in a cohort study ([@B77]). However, given that cocaine users frequently abuse other drugs and substances, the consequences of PCE at different stages of the trimester is not clearly defined ([@B57]).

Although animal studies clearly show that PCE in early developmental stages induces a more severe effects in neuronal migration than that in late developmental stages ([@B51]; [@B59]). The animals subjected to cocaine at 20 mg/kg twice a day during early/mid gestation periods (E13--E14 or E15--E16) showed similar levels of accumulation of postmitotic excitatory neurons in the ventricular zone of the cerebral cortex ([@B51]; [Table 1](#T1){ref-type="table"}). This indicates that the migration deficits can be explained by indirect effects due to changes in the proliferation and differentiation of NPCs in the germinal zone.

Disruption of C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C chemokine receptor type 4 (CXCR4) pathway is another potential mechanism of the neuronal migration defects that are elicited by cocaine exposure. Reduction of CXCR4 protein expression following exposure to cocaine was reported by [@B38]. They exposed human fetal brain-derived NPCs to cocaine *in vitro* and observed inhibition of cellular proliferation and directional migration toward CXCL12 as well as reduction of CXCR4 expression ([@B38]). Similarly, the positioning of the interneurons that express CXCR4 in upper cortical layers was disturbed in *Cxcr4* knockout mice, providing additional evidence that CXCR4 plays a role in neuronal migration ([@B93]). However, neither study replenishes CXCR4 to ameliorate the neuronal migration defects. This piece of data will strengthen the crucial role of CXCR4/CXCL12 signaling in neuronal migration, and indicate the potential of the signaling as a target of therapeutic intervention for NMDs.

[@B59] proposed that the reduction of brain-derived neurotropic factor (BDNF) post exposure to cocaine may also explain impaired migration of the interneurons ([Table 1](#T1){ref-type="table"}). The animals that were injected with 20 mg/kg of cocaine twice a day show defects not only in radial migration of excitatory neurons but also in tangential migration of inhibitory neurons ([@B59]). These defects were associated with a transient decrease in BDNF protein expression ([@B59]). BDNF plays a pivotal role in neurogenesis in the developing cerebral cortex, and its interaction with CXCR4 has been reported ([@B68]; [@B4]). In fact, [@B106] demonstrated that BDNF significantly enhances the directional migration of human NPCs toward CXCL12. Furthermore, the presence of BAMD3100, a blocker of CXCR4, completely abolishes the migration, suggesting that BDNF-mediated chemotaxis toward CXCL12 is through CXCR4 activation ([@B106]). Although how BDNF and CXCR4 interact during neuronal migration is still unclear, BDNF-mediated CXCL12/CXCR4 signaling may critically contribute to the impairment of neuronal migration under cocaine exposure.

Hypoxia
=======

Intrauterine hypoxia occurs when the fetus is deprived of an adequate supply of oxygen. The inadequate oxygen level may be caused by high altitude and pre-existing maternal cardiovascular diseases, including heart failure and pulmonary hypertension. Maternal anemia, infections, chronic inflammation, and smoking also limit the amount of oxygen delivered to the fetus ([@B40]). Chronic hypoxia during brain development affects radial and tangential migrations of excitatory and inhibitory neurons, respectively, thereby leading to the thinner cortical plate in newborn rats ([@B108]; [Table 1](#T1){ref-type="table"}). [@B101] demonstrated a short period of hypoxia at E14 or E18 impairs radial migration. Notably, hypoxia at E14, but not at E18, disturbed lateral dispersion of excitatory neurons in cortical minicolumns ([Table 1](#T1){ref-type="table"}). This finding indicates that the occurrence of neuronal migration defects due to prenatal hypoxia is timing-dependent. The fetal brain in earlier gestation period may be more susceptible to hypoxia-induced disturbance of neuronal migration. However, the relationship between the timing and severity of neuronal migration defect is still unclear, and thus more investigations are required.

One of the potential mechanisms underlying the impaired neuronal migration under prenatal hypoxia is the activation of lysophosphatidic acid (LPA) signaling. [@B36] demonstrated that LPA signaling is activated by acute prenatal hypoxia in mice ([Table 1](#T1){ref-type="table"}). LPA is a lysophospholipid that activates LPA receptors and affects neurogenesis, neuronal migration, neuritogenesis, and myelination ([@B41]). Notably, hypoxia-induced impaired neuronal migration was mitigated in E13 brain slices of Lpa1 receptor knockout mice exposed to hypoxia for 17 h. This observation suggests that defects of neuronal migration under hypoxia is mediated by Lpa1 receptor ([@B36]).

Valproic Acid
=============

Maternal use of valproic acid (VPA), an anti-epileptic drug, during pregnancy is closely associated with increased frequency of congenital malformation and neuropsychiatric disorders in human ([@B60]). A cohort study comparing the various anti-epileptic drugs that are prescribed to pregnant women found that the risks of fetal malformation increase in a dose-dependent manner. VPA exposure especially presents a greater risk of major congenital malformation compared to other antiepileptic drugs such as carbamazepine, lamotrigine, and phenobarbital ([@B95]). VPA at daily doses of 1000 mg or higher is clearly associated with developmental abnormalities, thus frequent consumption of the VPA at reduced dose is recommended control epilepsy during pregnancy ([@B69]). Of note, the manifestation of autism is also strongly associated with prenatal exposure to VPA. Children who are exposed to VPA prenatally have a three-fold higher risk of developing autism ([@B13]). Therefore, the mouse model of prenatal exposure to VPA has been widely used as one of non-genetic ASD models. In fact, these animals mimic many of ASD-like behaviors, such as social interaction deficits, repetitive self-grooming, digging, and deficiency in sensory processing ([@B81]; [@B65]).

The exact mechanism of how VPA treats epilepsy is not fully understood, yet proposed mechanisms include alteration of GABA levels, blockade of voltage-gated sodium channels (VGSCs) and inhibition of histone deacetylases ([@B80]). All of which may contribute to abnormal brain development. For example, blocking or enhancing GABA~A~ receptor diminished or promoted the migration of MGE-derived interneurons into the cerebral cortex, respectively ([@B15]), demonstrating ambient level of GABA is important for stimulating the migrating neurons. Similarly, the activation of VGSCs induced Ca^2+^ signaling in GABA-mediated migration of oligodendrocyte precursor cells, and the knockdown of VGSCs by siRNA diminished intracellular Ca^2+^ level and reduced the migration ([@B96]). Thus, the blockage of VGSCs in neurons by VPA can lead to neuronal migration impairment via similar mechanism.

In addition, prenatal exposure to VPA during the peak of cortical neurogenesis in mice changes expressions of the genes that are associated with the cell migration, including BDNF and *Cxcr4*. This results in the mislocalization of excitatory neurons in the cerebral cortex in these animals ([@B1]; [@B82]; [Table 1](#T1){ref-type="table"}). It indicates that disturbance of BDNF/CXCL12/CXCR4 signaling is another potential mechanism underlying the deficiency of the neuronal migration by prenatal VPA exposure.

Selective Serotonin Reuptake Inhibitor
======================================

Selective serotonin reuptake inhibitors (SSRIs) are commonly used to treat depression during pregnancy. The human imaging study demonstrated a significant increase of the gray matter volume in amygdala and insula along with increased connectivity in children exposed to SSRI prenatally ([@B53]). The expression of the genes involved in serotonin signaling starts during the early stage of fetal brain development, and the disruption of serotonin signaling pathway affects cell proliferation, differentiation, neuronal migration and network formation in various regions of the brain ([@B91]).

The differential effects of SSRI depending upon the given dosage and/or timing is obscure. A study has shown that the children exposed to SSRIs in late pregnancy (\>29 weeks) is strongly associated with increased risk of anxious or depressed behaviors ([@B54]). Whereas another study has shown that the length of SSRI exposure rather than the timing crucially contributes to the outcome of the fetal development ([@B67]). Similarly, another study shows that extended SSRI exposure in prenatal period increases the risks of lower scores in psychomotor developmental index and behavioral rating scale in infancy ([@B12]).

Given that the polymorphisms of the genes encoding the serotonin transporters and receptors are strongly associated with neurodevelopmental disorders such as ASD ([@B2]), both reduced and increased levels of serotonin signaling are proposed to cause devastating consequence in brain development. Consistent with this hypothesis, excessive activation of serotonin signaling disturbed the migration of pyramidal neurons in the cortex of the serotonin transporter (*Sert*) knockout (KO) mouse, in which serotonin accumulated extracellular and the activation of serotonin receptors was extended ([@B75]; [Table 1](#T1){ref-type="table"}). The authors also demonstrated that excess activation of a subtype of serotonin receptor 5-HT~6~ that is expressed in the developing excitatory neurons disturbed the migration in the *Sert* KO cerebral cortex. In line with the hypothesis above, downregulation of 5-HT~6~ receptor also resulted in mislocalization of pyramidal neurons in the mouse cortex ([@B44]). Given that serotonin signaling also interacts with BDNF signaling, the migration may be disrupted by, at least in part, the similar mechanism observed in the cases of prenatal exposure to cocaine and VPA as described above ([@B91]).

Methylmercury
=============

Exposure to a high level of heavy metal, such as methylmercury, is associated with neuropsychological problems. Methylmercury ingested by a pregnant woman is absorbed in the gastrointestinal tract and forms a placenta-crossing complex with [L]{.smallcaps}-cysteine ([@B8]). Children exposed to methylmercury in the prenatal period show deficits in finger tapping speed, reaction time on a continuous performance task, and cued naming ([@B18]). A classic example of neurotoxicity due to prenatal methylmercury exposure is patients of Minamata disease. The brain development of these patients is severely compromised, resulting in ataxia, dysarthria, and tremor ([@B33]).

Similar to the cases of fetal exposure to alcohol described in previous section, mice that were exposed to methylmercury from postnatal day 6 to 9, the peak of neuronal migration in the cerebellum, showed a decrease in the frequency of spontaneous Ca^2+^ dynamics as well as impaired migration of cerebellar granular cells (CGCs) ([@B22]; [Table 1](#T1){ref-type="table"}). Notably, the migration defects were ameliorated by caffeine supplementation, which induces Ca^2+^ release by binding to ryanodine receptors in the brain and stimulating internal Ca^2+^ release and Ca^2+^ influx ([@B100]; [@B22]). Additionally, a proteomic study of mouse embryo exposed to methylmercury reported a decrease in the phosphorylated form of cofilin in CGCs ([@B103]). LIM-kinase 1 (LMK-1)-mediated phosphorylation inactivates cofilin, by which prevents disassembly of actin filaments. Therefore, the change of phosphorylation ratio of cofilin would disrupt the actin dynamics in the filopodia of migrating CGCs ([@B107]; [@B25]; [@B24]).

Chronic exposure to methylmercury, even at a very low dose of 0.1 mg/kg/day, affects neuronal migration in the developing rat cerebral cortex. Methylmercury suppresses protein expressions of Rac family small GTPase 1 (RAC1), Cell division cycle 42 (CDC42), and Ras homolog gene family, member A (RHOA), all of which are key players of radial migration in the developing brain ([@B28]; [@B31]; [Table 1](#T1){ref-type="table"}). Altogether, similar to alcohol, methylmercury changes the Ca^2+^ signaling and the expressions of genes or proteins that are closely linked to the control of cortical neuronal migration.

Another potential mechanism of methylmercury affecting the neuronal migration may be the serotonin signaling. Placental serotonin, which is synthesized from maternal tryptophan precursor, is required for neuronal migration during the forebrain development ([@B7]). Methylmercury not only inhibits cellular proliferation and migration, but also alters the expressions of oxidative stress-related genes such as superoxide dismutase 1 (SOD1) in human placenta-derived trophoblasts ([@B99]). The vulnerability of the trophoblasts to methylmercury suggests the potential effects on placental development ([@B37]). Therefore, the maldevelopment of the placenta under exposure to methylmercury leads not only to the loss of protection for the fetus but also to disrupted production of the neurotransmitters required for proper neuronal migration.

Glucocorticoids
===============

Glucocorticoids (GCs) are a class of corticosteroids that are prescribed to pregnant women to promote lung maturation in fetuses when they are at risk of preterm delivery ([@B55]). Synthetic GC binds to the endogenous GC receptors in the fetal lung and promotes the maturation by increasing a production of the surfactant-associated proteins and phospholipids, both of which are crucial for stable lung function ([@B6]).

The benefits of GC treatment for fetal lung maturation may come with a cost as studies show that the excess prenatal steroid exposure is associated with a wide spectrum of deficits in brain development, such as loss of hippocampal neurons, delayed myelination, and increased risk of neurodevelopmental disability ([@B102]). Structural abnormalities including reduced cortical thickness in frontal cortex and rostral anterior cingulate cortex (rACC) were also evident in children who had been exposed to GC prenatally ([@B63]; [@B17]). Different dosages and timing of GC exposure may have differential effects on the developing brain. Treatment prior to mid-gestation may be well tolerated by the fetus without adverse effects due to the relatively high expression of a GC degrading enzyme, 11β-hydroxysteroid dehydrogenase (11β-HSD2), in the placenta and the fetal brain before mid-gestation ([@B20]). In addition, the expressions of GC receptor transcripts start to arise in the pons, medulla, anterior hypothalamus, and spinal cord at mid-gestational stage of pregnancy (E12.5). Then gradually spread to the rest of brain regions such as neocortex in rats ([@B20]) which may increase the fetal susceptibility to GC.

Animal studies demonstrate that neuronal migration defect by GC exposure is mediated by alterations in the expression of key neuronal migration genes. The administration of GC retarded the radial migration of excitatory neurons in fetal cerebral cortex. These neurons also showed increase in *Cald1* expression. Consistent with this, overexpression of *Cald1* led to impaired neuronal migration *in vitro* ([@B26]; [Table 1](#T1){ref-type="table"}). *Cald1* encodes Caldesmon that negatively regulates the function of myosin II, an essential protein for the actin dynamics in the leading process of neuron. The upregulation of *Cald1* inhibits interactions between actin and myosin II in the radially migrating neurons, thereby disrupting the migration ([@B90]; [@B64]).

Interneurons in offspring of dams that underwent daily physical stress (restraint stress) exposure starting from E12 until birth show delayed migration without changes in the survival or proliferation ([Table 1](#T1){ref-type="table"}; [@B92]). The expressions of transcription factors *dlx2* and *nkx2.1* in the fetal brains are significantly decreased as early as 24 h after the first stress exposure ([@B92]). These transcription factors are important in determining cell fate and migration of interneuron ([@B66]). Overall, excess GC affects neuronal migration altering the expressions of the genes that directly and indirectly modulate the neuronal migration.

Maternal Immune Activation
==========================

Maternal immune activation (MIA) is caused by an infection during pregnancy, and it is linked to increased risk of ASD and schizophrenia ([@B71]). Maternal infection to human influenza virus during pregnancy resulted in ectopic cluster formation of Purkinje cells (PC) in the white matter of cerebellar lobules VI and VII in mouse, while the number of PC decreased in lobule VII ([@B87]; [Table 1](#T1){ref-type="table"}). A similar reduction in the number of PC in lobule VII was observed in mice born to mothers inoculated with an immunostimulant, poly(I:C) ([@B87]). These reports suggest that MIA disrupts the migration of the PC during cerebellar development. Given a subclass of small cytokines functions as migrational cues for newly generated neurons, the excess production of maternal cytokines is likely to trigger misguidance of neurons in the fetal brain under MIA ([@B21]). MIA also altered the expressions of genes that are involved in the regulation of cell proliferation, migration, and axon guidance in the fetal brain ([@B70]; [@B52]). However, the contributions of each of such genes to the neuronal migration remain elusive.

Molecular Mechanisms Shared by Different Types of Environmental Stress
======================================================================

As described in previous sections, different types of prenatal environmental stress have common effects on the neuronal migration at the molecular level (Summarized in [Figure 2](#F2){ref-type="fig"}). An example described above is the BDNF/CXCL12/CXCR4 signaling. Many of the chemicals and stress listed in this review alter the expressions of genes involved in this pathway. Interestingly, both excessive and insufficient expressions and activations of the genes in this signaling disturb the neuronal migration. Similarly, as described above, both up- and down-regulation of serotonin signaling disturb neuronal migration.

![Schematic representation of mechanisms underlying neuronal migration defects elicited by exposure to environmental stress. The prenatal environmental stressors such as cocaine, VPA, SSRI, ethanol, methylmercury similarly, disturb interactions and functions of the molecules that are involved in the control of neuronal migration.](fcell-07-00138-g002){#F2}

How does CXCR4/CXCL12 signaling control the neuronal migration? The clues may be found in the genetic disorder, 22q11.2 deletion syndrome (22q11.2DS). The mouse model of 22q11.2DS shows neuronal migration defects due to decrease of *Cxcr4* ([@B61]). This phenotype is rescued by overexpression of the *Dgcr8* ([@B98]). DGCR8 forms a complex with Drosha to process primary microRNA (pri-miRNA) and facilitates microRNA (miRNA) maturation ([@B29]; [@B32]). This finding suggests that the disturbance of the CXCL12/CXCR4 pathway may change miRNA-mediated regulation of the transcriptions that control neuronal migration ([@B84]).

The environmental stress may alter the expressions of genes in the CXCL12/CXCR4 pathway via a different route. Heat shock transcription factor 1 -- hypoxia inducible factor-1 alpha (HSF1-HIF1α) pathway is a stress response signaling that is activated by various types of environmental stress in fetal brain ([@B35]; [@B42]; [@B97]), while HIF1α also directly transcribes *CXCR4* ([@B85]; [@B27]). Thus the HIF1α may transcribe *CXCR4* in response to environmental stress ([@B43]). On the other hand, overexpression of heat shock protein 70 (hsp70) that is transcriptionally regulated by HSF1 reduces *Cxcr4* expression ([@B83]).

Another common molecular trait shared by different types of environmental stress is the changes in expressions of genes that regulate the dynamics of the cytoskeleton. These changes happen partially through the activation of stress response signaling and the Ca^2+^ signaling ([@B50]; [@B22]; [@B52]).

Perspectives
============

Although animal models convey the mechanisms responding to environmental stress, what happens in the large human brain remains speculative. As rodents and humans do not share the identical mechanism of neuronal migration during the development of brain, studying brain development in a model that closely mimics human brain development is imperative ([@B86]). Therefore, the human pluripotent stem cell-derived three-dimensional organoid culture system, in which the cortical lamination and thick germinal zone are reproduced, may be a versatile tool to understand the molecular basis of neuronal migration defects in the human brain ([@B58]; [@B104]). However, current protocols of the brain organoid system often require culture conditions that increase the levels of reactive oxidative stress (ROS). Thereby an optimal protocol that allows testing the effects of environmental stress in organoids without high ROS level is still needed. An especially intriguing question to be answered by using the organoid system will be whether the pathways commonly disrupted during neuronal migration by different types of environmental stressors are similarly, or differently regulated in human brain organoid in comparison to animal models.
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